The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2023 | Patient-reported data in dose-finding clinical trials
Bellinda King-Kallimanis, PhD, LUNGevity Foundation, Tarpon Springs, FL, outlines the 2023 International Association for the Study of Lung Cancer (IASLC) webinar on the use of patient-reported data to optimise dose-finding clinical trials. The session explored the design of early phase dose-finding studies, the difficulties of those trials in the era of targeted therapies in contrast with chemotherapies, and how patient-reported data can complement clinician-reported data. Dr Kallimanis discusses the research presented by patient advocates on getting involved in working groups and conducting research with patient advocacy in mind. This interview took place at the 2023 World Conference on Lung Cancer (WCLC) in Singapore, Singapore.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
